Last reviewed · How we verify
Sublingual Misoprostol
Sublingual Misoprostol is a Small molecule drug developed by Stony Brook University. It is currently FDA-approved. Also known as: experimental, two tablets of Cytotec (200 μg), cytotec, Prostokos.
Sublingual misoprostol is a small molecule used to treat various conditions, including bleeding during myomectomy, miscarriage, labor onset and length abnormalities, missed miscarriage, and incomplete abortion. It is administered sublingually, a method of administration where the medication is placed under the tongue.
At a glance
| Generic name | Sublingual Misoprostol |
|---|---|
| Also known as | experimental, two tablets of Cytotec (200 μg), cytotec, Prostokos, Cytotec |
| Sponsor | Stony Brook University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Sublingual Misoprostol Versus No Cervical Priming Before Hysteroscopic Resection of Symptomatic Uterine Niches (NA)
- Tranexamic Acid Versus Sublingual Misoprostol in Reducing Blood Loss During Elective CS in High Risk Cases (PHASE2)
- Comparison of the Efficacy of Misoprostol and Tranexamic Acid for Postpartum Hemorrhage Prophylaxis in Cesarean Delivery
- Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage (PHASE3)
- Foley Balloon for Cervical Preparation Before Dilation and Evacuation (NA)
- Comparison Between Preoperative Vaginal and Postoperative Sublingual Misoprostol for Prevention of Postpartum Hemorrhage During Cesarean Section (PHASE3)
- Letrozole Versus Mifepristone and Misoprostol in Silent Miscarriage (NA)
- Vaginal Misoprostol In Management Of First Trimester Missed Abortion. (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sublingual Misoprostol CI brief — competitive landscape report
- Sublingual Misoprostol updates RSS · CI watch RSS
- Stony Brook University portfolio CI
Frequently asked questions about Sublingual Misoprostol
What is Sublingual Misoprostol?
Who makes Sublingual Misoprostol?
Is Sublingual Misoprostol also known as anything else?
What development phase is Sublingual Misoprostol in?
Related
- Manufacturer: Stony Brook University — full pipeline
- Also known as: experimental, two tablets of Cytotec (200 μg), cytotec, Prostokos, Cytotec
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing